Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Robert M. Elashoff, Ph.D.
Robert M. Elashoff, Ph.D.


Professor, Department of Biostatistics, Department of Biomathematics
Leader, UCLA Clinical and Translational Science Institute (CTSI) Joint Biostatistics Program
Co-Director, JCCC Biostatistics, Analytic Support and Evaluation (BASE) Shared Resource
Director, JCCC Protocol Review and Monitoring System Shared Resource
Member, JCCC Community

Contact Information:

(310) 794-5861

Scientific Interest(s):

Dr. Robert Elashoff's research focuses on survival analysis, repeated measure analysis and clinical trial design and analysis.

Selected Cancer-Related Publications:

Elashoff RM, Li G, Zhou Y. Nonparametric Infer-ence for Assessing Treatment Efficacy in Randomized Clinical Trials with A Time-to-Event Outcome and All-or-None Treatment-Noncompliance Biometrika. 2012;99(2):393-404.

Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011 Jul;141(1):150-6. Epub 2011 Feb 18

Altstein LL, Li G, Elashoff RM. A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial. Stat Med. 2011 Mar 30;30(7):709-17. Epub 2010 Nov 30

Li N, Elashoff RM, Li G. Robust joint modeling of longitudinal measurements and competing risks failure time data. Biom J. 2009 Feb;51(1):19-30.

Elashoff RM, Li G, Li N. A joint model for longitudinal measurements and survival data in the presence of multiple failure types. Biometrics. 2008 Sep;64(3):762-71. Epub 2007 Dec 20